A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia

Jonathan Canaani, Ivetta Danylesko, Noga Shemtov, Maya Zlotnick, Kira Lozinsky, Ohad Benjamini, Ronit Yerushalmi, Meital Nagar, Chen Dor, Avichai Shimoni, Abraham Avigdor, Arnon Nagler*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science